ATE481111T1 - Pax2 zur behandlung von nierenkrankheiten - Google Patents

Pax2 zur behandlung von nierenkrankheiten

Info

Publication number
ATE481111T1
ATE481111T1 AT01921268T AT01921268T ATE481111T1 AT E481111 T1 ATE481111 T1 AT E481111T1 AT 01921268 T AT01921268 T AT 01921268T AT 01921268 T AT01921268 T AT 01921268T AT E481111 T1 ATE481111 T1 AT E481111T1
Authority
AT
Austria
Prior art keywords
inducing
enhancing
substance capable
pax2
pax2 expression
Prior art date
Application number
AT01921268T
Other languages
English (en)
Inventor
Uwe Rothenpieler
Michael Imgrund
Original Assignee
Rothenpieler Uwe Waldemar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rothenpieler Uwe Waldemar filed Critical Rothenpieler Uwe Waldemar
Application granted granted Critical
Publication of ATE481111T1 publication Critical patent/ATE481111T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01921268T 2000-01-31 2001-01-31 Pax2 zur behandlung von nierenkrankheiten ATE481111T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17912900P 2000-01-31 2000-01-31
PCT/EP2001/001004 WO2001054706A2 (en) 2000-01-31 2001-01-31 Method for treating kidney disorders

Publications (1)

Publication Number Publication Date
ATE481111T1 true ATE481111T1 (de) 2010-10-15

Family

ID=22655340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01921268T ATE481111T1 (de) 2000-01-31 2001-01-31 Pax2 zur behandlung von nierenkrankheiten

Country Status (9)

Country Link
EP (1) EP1255569B1 (de)
AT (1) ATE481111T1 (de)
AU (1) AU2001248307A1 (de)
CA (1) CA2398310C (de)
DE (1) DE60143078D1 (de)
DK (1) DK1255569T3 (de)
ES (1) ES2351957T3 (de)
PT (1) PT1255569E (de)
WO (1) WO2001054706A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1890716A2 (de) * 2005-06-16 2008-02-27 Hadasit Medical Research Services & Development Co. Ltd. Verfahren zur behandlung von niereninsuffizienz
EP3147296A1 (de) * 2005-11-14 2017-03-29 Merial, Inc. Gentherapie für nierenversagen
ES2341419B1 (es) * 2008-08-14 2011-05-03 Hospital Clinic I Provincial De Barcelona Wnt1 como biomarcador de daño renal.
US20120149110A1 (en) * 2009-08-17 2012-06-14 Organ Technologies Inc. Process for production of bioartificial organ
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
US5750495A (en) * 1996-03-26 1998-05-12 The Regents Of The University Of California Treatment of cystic disease with TNF-α
US5882923A (en) * 1996-06-27 1999-03-16 Sariola; Hannu Glial cell line-derived neurotrophic factor regulation of ureteric budding and growth
US5976524A (en) * 1997-01-06 1999-11-02 Washington University Chimeric kidney
ATE308337T1 (de) * 1997-03-15 2005-11-15 Nakamura Toshikazu Hgf zur behandlung von akutem nierenversagen
CA2289123A1 (en) * 1997-05-05 1998-11-12 Creative Biomolecules, Inc. Therapies for acute renal failure

Also Published As

Publication number Publication date
WO2001054706A2 (en) 2001-08-02
DE60143078D1 (de) 2010-10-28
AU2001248307A1 (en) 2001-08-07
CA2398310A1 (en) 2001-08-02
EP1255569A2 (de) 2002-11-13
WO2001054706A3 (en) 2002-01-24
DK1255569T3 (da) 2010-12-06
CA2398310C (en) 2015-11-24
PT1255569E (pt) 2010-11-19
ES2351957T3 (es) 2011-02-14
EP1255569B1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
ATE481111T1 (de) Pax2 zur behandlung von nierenkrankheiten
DE60023476D1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20070702L (no) Kombinasjonsbehandling for ikke-hematologisk malignitet ved anvendelse av anti-OGF-1R antistoff
DK200000792A (da) Lindring af Peyronie's sygdom
DE602004018944D1 (de) Verwendung von abführmittel zur behandlung des reizdarmsyndroms
BR0015407A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para estimular a liberação de hormÈnio do crescimento da glândula pituitária de um mamìfero e para aumentar a taxa e o grau de crescimento, a produção de leite e de lã ou para o tratamento de dores, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
DE60140191D1 (de) Zusammensetzungen mit matrixproteinen zur regeneration von dentin
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
JP2003528919A5 (de)
ATE499933T1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
PL368686A1 (en) Novel aminobenzoephenones
RU2008148334A (ru) Водный экстракт листьев табака и его применение при лечении зависимости
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
ATE303816T1 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
ATE265225T1 (de) Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
DE50214008D1 (de) Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE466587T1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
ATE380555T1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1255569

Country of ref document: EP